10/30/25 19:02  | 10/28/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | S | -1,001 | 25.03 | 0 | -40 | -4 | 1,040 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/3/25 17:02  | 10/1/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | S.m | -885 | 19.66 | 0 | -45 | -4 | 1,080 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/10/25 18:21  | 9/8/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | S.m | -178 | 17.54 | 0 | -10 | -1 | 1,125 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/25 18:29  | 8/4/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | S | -165 | 14.33 | 0 | -12 | -1 | 1,135 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/5/25 17:20  | 5/2/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -174 | 15.19 | 0 | -11 | -1 | 1,145 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/25 16:41  | 3/24/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -64 | 17.55 | 0 | -4 | 0 | 1,156 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/20/25 18:27  | 3/17/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -21 | 17.61 | 0 | -1 | 0 | 1,160 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/25 19:43  | 3/3/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.dm | -327 | 13.07 | 0 | -25 | -2 | 1,161 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/4/25 20:01  | 2/3/25  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -245 | 12.70 | 0 | -19 | -2 | 1,035 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/23/24 19:22  | 12/20/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -228 | 15.17 | 0 | -15 | -1 | 1,055 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/3/24 16:16  | 5/31/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | P.m | 21 | 3.52 | 0 | 6 | 1 | 1,070 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/5/24 16:46  | 11/4/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -120 | 8.68 | 0 | -14 | -1 | 1,064 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/24 16:37  | 8/2/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -131 | 9.02 | 0 | -14 | -1 | 1,077 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/3/24 16:22  | 5/2/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -120 | 8.74 | 0 | -14 | -1 | 1,092 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/6/24 17:09  | 3/4/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -166 | 11.12 | 0 | -15 | -1 | 1,106 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/24 16:11  | 2/28/24  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -26 | 10.60 | 0 | -2 | 0 | 1,121 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/1/23 20:51  | 12/1/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | M.d | 100 | 1.68 | 0 | 60 | 9 | 733 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/1/23 20:51  | 5/31/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | P.d | 9 | 6.38 | 0 | 1 | 0 | 733 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/8/23 16:29  | 3/6/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -37 | 15.26 | 0 | -2 | 0 | 585 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/2/23 19:06  | 2/28/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -124 | 15.93 | 0 | -8 | -1 | 587 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 19:09  | 2/13/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -17 | 17.01 | 0 | -1 | 0 | 595 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/3/23 16:26  | 2/1/23  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.00 | 0 | -1 | 0 | 596 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/9/22 16:47  | 12/7/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.06 | 0 | -1 | 0 | 597 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/22 16:39  | 11/7/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -18 | 18.00 | 0 | -1 | 0 | 598 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/11/22 18:47  | 10/7/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -20 | 19.51 | 0 | -1 | 0 | 599 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/9/22 17:10  | 9/7/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.51 | 0 | -1 | 0 | 600 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/12/22 19:30  | 7/8/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -342 | 25.37 | 0 | -14 | -2 | 870 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/12/22 19:30  | 7/8/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 12 | 1.68 | 0 | 7 | 1 | 870 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/7/22 16:04  | 7/6/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 22.07 | 0 | -1 | 0 | 876 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/6/22 16:06  | 6/6/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.06 | 0 | -1 | 0 | 877 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/5/22 17:31  | 5/5/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.76 | 0 | -1 | 0 | 877 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/22 18:45  | 4/5/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.43 | 0 | -1 | 0 | 878 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/11/22 21:42  | 3/9/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -5 | 17.00 | 0 | 0 | 0 | 879 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/7/22 20:59  | 3/4/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.dm | -55 | 16.90 | 0 | -3 | 0 | 879 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/7/22 20:59  | 3/7/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 879 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/3/22 16:18  | 3/1/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -38 | 17.75 | 0 | -2 | 0 | 811 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/11/22 17:55  | 2/9/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/11/22 17:55  | 2/9/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/22 16:17  | 1/5/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/22 16:17  | 1/5/22  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.59 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/10/21 18:41  | 12/8/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/10/21 18:41  | 12/8/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/21 17:19  | 11/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/21 17:19  | 11/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.50 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/7/21 16:05  | 10/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 4 | 1.68 | 0 | 3 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/7/21 16:05  | 10/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -62 | 24.92 | 0 | -3 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/5/21 14:10  | 10/1/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/5/21 14:10  | 10/1/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -38 | 25.01 | 0 | -2 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/9/21 17:42  | 9/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/9/21 17:42  | 9/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 21.14 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/21 18:51  | 8/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/21 18:51  | 8/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 20.81 | 0 | -1 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/8/21 19:40  | 7/6/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/8/21 19:40  | 7/6/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -47 | 26.58 | 0 | -2 | 0 | 813 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/9/21 16:35  | 6/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 805 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/9/21 16:35  | 6/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -46 | 26.35 | 0 | -2 | 0 | 805 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/11/21 11:47  | 5/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 804 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/11/21 11:47  | 5/7/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -26 | 35.00 | 0 | -1 | 0 | 804 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/7/21 11:29  | 5/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 804 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/7/21 11:29  | 5/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -60 | 34.00 | 0 | -2 | 0 | 804 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/4/21 15:00  | 4/30/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -53 | 35.00 | 0 | -2 | 0 | 805 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/6/21 17:30  | 4/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -52 | 29.93 | 0 | -2 | 0 | 806 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/5/21 15:56  | 3/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -53 | 30.55 | 0 | -2 | 0 | 808 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/3/21 16:51  | 3/2/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -74 | 35.19 | 0 | -2 | 0 | 777 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/8/21 16:00  | 2/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 17 | 1.68 | 0 | 10 | 1 | 779 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/8/21 16:00  | 2/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -343 | 34.29 | 0 | -10 | -1 | 779 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 15:13  | 1/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.ad | 17 | 1.68 | 0 | 10 | 1 | 779 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 15:13  | 1/5/21  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.ad | -281 | 28.08 | 0 | -10 | -1 | 779 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 14:39  | 9/29/20  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 14:39  | 9/29/20  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/20 21:02  | 9/29/20  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/20 21:02  | 9/29/20  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/16/20 18:05  | 3/13/20  | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 100 | 1.68 | 0 | 59 | 8 | 778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |